Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
deals
5
×
national blog main
life sciences
san francisco blog main
boston blog main
fda
national top stories
new york blog main
startups
akouos
cancer
clinical trials
detroit blog main
ipo
medical devices
new york top stories
san diego blog main
san diego top stories
san francisco top stories
vc
venture capital
wisconsin blog main
wisconsin top stories
30ventures
abbvie
alex gorsky
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
armo biosciences
ashley mcevoy
astellas pharmaceuticals
astrazeneca
auris health
autoimmune
avalon ventures
biogen
What
plans
5
×
ipo
deal
medicines
raise
acquiring
acquisitions
additions
advance
affects
americans
announced
approved
auris
based
billion
bio
biology
builds
buy
capital
cash
ceo
chemistry
collabs
company
company’s
covid
cytokine
daniel
date
debut
details
developer
developing
disclosed
document
drug
drugs
enhanced
Language
unset
Current search:
plans
×
biotech
×
deals
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
30Ventures Seeks $15M to Fund Startups in Healthcare, Water Tech